Cipla's Protein-bound Paclitaxel is an AB-rated generic therapeutic equivalent version of Bristol Myers Squibb's Abraxane for Injectable Suspension 100 mg/vial. Protein-bound Paclitaxel is indicated ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch1 of Vancomycin Hydrochloride for Injection USP, 750 ...

announced Tuesday the launch of Vancomycin Hydrochloride for Injection USP in single-dose vials of 750 mg/vial, 1.25 g/vial and 1.5 g/vial. The company noted that its Vancomycin Hydrochloride for ...

Cipla's protein-bound paclitaxel is a generic therapeutic equivalent version of Bristol Myers Squibb's Abraxane for injectable suspension 100 mg/vial. Protein-bound paclitaxel is indicated for the ...

To develop a robust manufacturing process, contract developers want to understand and derisk their processes better.

1Glenmark's Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-dose vial) is only approved for the indication(s) listed in Glenmark's approved label.

The injection is also prescribed for pathological hypersecretion conditions, including Zollinger-Ellison (ZE) Syndrome.

Cipla has secured USFDA approval to market a generic cancer treatment, specifically paclitaxel protein-bound particles.

Community health centre Panki is in the vortex of the controversy. Here a patient is alleged to have been given injection of higher antibiotic the vial of which had expired long ago in July 2024. The ...